Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database
Abstract Background Metabolism dysfunction-associated fatty liver disease (MAFLD), is the most common chronic liver disease. Few MAFLD predictions are simple and accurate. We examined the predictive performance of the albumin-to-glutamyl transpeptidase ratio (AGTR), plasma atherogenicity index (AIP)...
Main Authors: | Xu Ming Li, Song Lian Liu, Ya Jun He, Jian Chang Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-024-03190-2 |
Similar Items
-
Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis
by: Yilian Xie, et al.
Published: (2023-05-01) -
MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
by: Huang J, et al.
Published: (2021-02-01) -
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
by: Kamlesh K. Bhopale, et al.
Published: (2023-10-01) -
Development and validation of a new nomogram to screen for MAFLD
by: Haoxuan Zou, et al.
Published: (2022-12-01) -
Healthy Eating Index-2015 in relation to risk of metabolic dysfunction-associated fatty liver disease among US population: National Health and Nutrition Examination Survey 2017–2018
by: Wei Zhang, et al.
Published: (2023-01-01)